30.10.2013 Views

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical genetics<br />

tion, cardiac malformations, cranio-facial dysmorphisms and pigmentary<br />

skin anomalies following the lines of Blaschko. The chromosomal<br />

analysis of peripheral blood cells was normal, but 69,XXY/46,XY mosaicism<br />

was detected in skin fibroblast culture.A thorough examination<br />

of the patient at the age of <strong>16</strong> revealed the usual features typical<br />

for this type of chromosomal mosaicism (asymmetric face, prominent<br />

and wide nasal bridge, clinodactyly, mental retardation, hypotonia,<br />

patchy pigmentation and depigmentation of skin, cardiac malformations,<br />

and truncular obesity), but also the absence of one of the inferior<br />

incisors and alternating vertical bands of opaque white and translucent<br />

enamel most evident on the central and lateral incisors. These<br />

dental abnormalities represent the anatomic equivalent of cutaneous<br />

Blaschko lines. Extracutaneous analogies of Blaschko lines have been<br />

described in various organs, such as the brain, bone, lens and teeth.<br />

These lines do not follow any known nervous, vascular or lymphatic<br />

structures but do follow and represent the developmental growth pattern<br />

of the skin. The embryological basis of these lines has not up to<br />

now been elucidated.<br />

P0037. Blepharophimosis, Ptosis, and Epicantus inversus<br />

Syndrome (BPES). Clinical study about three cases<br />

L. I. Butnariu 1 , C. Rusu 1 , M. Covic 1 , V. Gorduza 1 , L. Trandafir 2 ;<br />

1 University of Medicine and Pharmacy “Gr. T. Popa”, Department of <strong>Human</strong><br />

<strong>Genetics</strong>, Iassy, Romania, 2 University of Medicine and Pharmacy “Gr. T. Popa”,<br />

“Saint Mary” Children Hospital, Iassy, Romania.<br />

BPES is a rare autosomal dominant disease (less than 1:5,000). It is<br />

a complex eyelid malformation invariably characterized by four major<br />

features: blepharophimosis, ptosis, epicantus inversus and telecanthus.<br />

There are two types of BPES: type I associate the typical features<br />

with female infertility caused by premature ovarian failure and<br />

type II includes only palpebral anomalies.<br />

We present two familial and one sporadic case of BPES. The diagnosis<br />

was based by clinical signs.<br />

Case 1, sporadic, G.L, male, 1 years old. There are no other relatives<br />

affected. We note, normal pregnancy, newborn haemolytic disease,<br />

febrile seizures and spastic tetraparesis. Clinical and paraclinic evaluation<br />

revealed: typical BPES features, low-set ears, narrow external<br />

auditory meatus, bifid uvula, internal hydrocephaly, atrial septal defect<br />

and developmental delay.<br />

Case 2, I.B, male, 6 years old, present clinical features of BPES type<br />

I, like his own father; his mother had sensorineural hypoacusy. Other<br />

features are tall stature, sparse hair, normal intelect. There are no<br />

other relatives affected.<br />

Case 3, A.D, female,1 years old, present on clinical evaluation typical<br />

ocular features, low nasal bridge, low-set ears and normal intelect. The<br />

father and other 7 relatives on paternal side (males and females) have<br />

the same features of BPES type I: only males are transmitting, affected<br />

females are infertile. The karyotype was normal in all three patients.<br />

In conclusion, we emphasize the importance of the clinical features for<br />

diagnosis, leading further to an apropiate management.<br />

P0038. Changes in Phenotype of Bloom´s Syndrome with New<br />

Manifestations in Adult Individuals<br />

E. Passarge, H. Löser;<br />

Institut für <strong>Human</strong>genetik, Universitätsklinikum Essen, Essen, Germany.<br />

Bloom´s syndrome results from autosomal recessive mutations in the<br />

BLM gene located on human chromosome 15 at 15q26.1, encoding<br />

a DNA helicase with homology to RecQ in E. coli (MIM 210900). Its<br />

phenotype includes (i) pre- and postnatal growth retardation, (ii) facial<br />

features with dolichocephaly and a narrow face, (iii) light-sensitive<br />

facial telangiectasia in most patients, (iv) manifestations of genomic<br />

instability as revealed by a 10-fold increase of spontaneous sister<br />

chromatid exchanges, breaks and homologous exchanges between<br />

chromosomes, and an increased rate of somatic mutations. Affected<br />

individuals develop similar types of cancer as in the population, but<br />

at a much younger age (about 1 in 4). We have observed the natural<br />

history in 15 individuals with Bloom´s syndrome during the past 38<br />

years in Germany. We found that the phenotype in adult individuals<br />

becomes less distinctive with age than it is in children. In spite of persistent<br />

feeding difficulties, such as lack of appetite or regurgitation,<br />

adult individuals tend to gain weight. A new finding is development of<br />

diabetes mellitus type 1 or type 2. This has been observed in 27 of 117<br />

patients (23%) of individuals in the Bloom´s Syndrome Registry (J.<br />

German, M. Sanz, E. Passarge, unpublished data). The skin manifestations<br />

tend to improve with age. We conclude that the phenotype of<br />

Bloom´s syndrome is wider than recorded previously. It remains to be<br />

seen whether the molecular type of mutation present in an individual<br />

influences the phenotype.<br />

We thank J. German, N.A. Ellis, and M. Sanz, New York, for cooperation<br />

and mutational analysis.<br />

P0039. Implementation of a new high throughput sequencing<br />

service for BRCA1 and BRCA2 gene screening to comply with<br />

UK Government <strong>Genetics</strong> White Paper 40 day turnaround time<br />

Y. Wallis, N. Motton, N. Morrell, C. Morgan, E. Ormshaw, J. Bell, F. Macdonald;<br />

West Midlands Regional <strong>Genetics</strong> Service, Birmingham, United Kingdom.<br />

In response to UK Government targets for BRCA gene screening (<strong>Genetics</strong><br />

White Paper) the West Midlands Regional Diagnostic <strong>Genetics</strong><br />

Laboratory (Birmingham, UK) devised a novel sequencing-based<br />

strategy to screen the large BRCA1 and BRCA2 genes. The strategy is<br />

plate-based therefore facilitating the use of highly automated processes.<br />

63 new primer sets were designed to amplify the coding regions of<br />

both BRCA1 and BRCA2 genes simultaneously using a 2-plate system<br />

for each patient panel. Between September 2005 and January <strong>2007</strong><br />

a total of 731 diagnostic BRCA reports were issued as a result of the<br />

high throughput sequencing strategy. More than 98% of these reports<br />

were issued within 40 working days (from the date of sample receipt<br />

to date of report authorisation) with an average turnaround time for all<br />

731 samples of 24.9 days. 79% of samples were reported in less than<br />

30 days. 128 clearly pathogenic mutations have been identified in addition<br />

to 121 missense mutations and other unclassified variants. The<br />

Birmingham lab has also performed a number of follow-up studies to<br />

investigate the pathogenicity of missense and unclassified variants as<br />

well as undertaking RNA studies to determine the effect on splicing of<br />

deep intronic variants. The high throughput service has been used by<br />

a number of diagnostic genetics service laboratories and to date 100<br />

reports have been issued to them with an average reporting time of<br />

23 days. This high throughput BRCA sequencing service is available<br />

upon request from the West Midlands Regional <strong>Genetics</strong> Service.<br />

P0040. Familial Breast Cancer With Positive History In Father<br />

And Mother : A Case Report .<br />

R. Habibi;<br />

Royan Institute, Tehran, Islamic Republic of Iran.<br />

Background: A family history of breast cancer in a first-degree relative<br />

is reported in 13% of women with the disease. In turn, over 87% of<br />

women with a family history will not develop breast cancer. However,<br />

only 1% of women have multiple affected relatives, a history suggestive<br />

of a highly penetrant germ-line mutation.<br />

The probability of breast cancer associated with a mutation in BRCA1<br />

and BRCA2 genes increases if there are affected before menopause<br />

and /or have multiple cancers, if there is a case of male, breast cancer,<br />

or if family members also develop ovarian cancer. BRCA2 is associated<br />

more frequently with male breast cancer.<br />

Case report: We report a female case of invasive carcinoma who had<br />

37-year-old, and positive family history with paternal and maternal involvement.<br />

She had fibrosis, inflammation, and fact necrosis in right<br />

breast that negative for malignancy and also she had invasive carcinoma<br />

in left breast. For left breast, lumpectomy was performed .<br />

Conclusions: First, in such a cases probability of the BRCA1 mutation<br />

increases and BRCA2 mutation is possible. Then screening for<br />

these genes should be performed for them and the other members<br />

of relatives and genetic counseling is required, and as soon as clinical<br />

approach for other related cancers may be performed. Second,<br />

also other nongenetic causes in such a family may predispose cancer<br />

susceptibility .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!